Features September 2014 Issue

Metal-free Aortic Valve Shows Promise in Early Clinical Trials

The Direct Flow’s new aortic valve contains no metal parts.

Metal-free Aortic Valve Shows Promise in Early Clinical Trials

The new prosthetic valve appears to reduce the risk of aortic regurgitation, which can be a problem after replacement heart valves are implanted.

A prosthetic aortic valve that contains no metallic components demonstrated safety and effectiveness in an early trial. Led by Cleveland Clinic cardiologist Murat Tuzcu, MD, the study of the Direct Flow Medical system resulted in low rates of mortality and stroke, as well as minimal aortic regurgitation.

To continue reading this article you must be a paid subscriber.

Subscribe to Heart Advisor

Get the next year of HEART ADVISOR for just $20. That's a savings of $19 off the regular rate.

With your paid subscription you will receive unlimited access to all of our online content. That is over a decade of previous issues from Cleveland Clinic, the hospital rated #1 in cardiac care by U.S. News & World Report - free of charge.

Subscriber Log In

Forgot your password? Click Here.

Already subscribe but haven't registered for all the benefits of the website? Click here.